Amgen Bundling Discounts Will Continue As J&J Case Heads To Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Court denies injunction sought by J&J to stop Amgen discounts based on amount of anemia products purchased.
You may also be interested in...
Amgen Pays $200M To Settle Antitrust Claim
No wrongdoing admitted in case filed by Ortho Biotech over anemia drugs.
Amgen Pays $200M To Settle Antitrust Claim
No wrongdoing admitted in case filed by Ortho Biotech over anemia drugs.
J&J Procrit Grows In Q1 Despite Challenges For ESAs
U.S. sales of the erythropoiesis-stimulating agent grew 1 percent in Q1 on strong sales in the hospital and retail market.